167 related articles for article (PubMed ID: 4677063)
1. [Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics].
Mattern J; Volm M; Wayss K
Arzneimittelforschung; 1972 Oct; 22(10):1721-2. PubMed ID: 4677063
[No Abstract] [Full Text] [Related]
2. [Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions].
Volm M; Kaufmann M; Mattern J; Wayss K
Schweiz Med Wochenschr; 1975 Jan; 105(3):74-82. PubMed ID: 1121657
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of D-glucosamine on the growth of Walker 256 carcinosarcoma and on protein, RNA, and DNA synthesis.
Bekesi JG; Winzler RJ
Cancer Res; 1970 Dec; 30(12):2905-12. PubMed ID: 5494575
[No Abstract] [Full Text] [Related]
4. [On the question of preclinical selection of cytostatics in the area of treatment of human tumors].
Wüst GP
Arzneimittelforschung; 1969 May; 19(5):817-9. PubMed ID: 4184536
[No Abstract] [Full Text] [Related]
5. [Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats].
Karaivanova MK
Eksp Med Morfol; 1974; 13(4):237-42. PubMed ID: 4219353
[No Abstract] [Full Text] [Related]
6. Screening of Venezuelan poisonous plants for anticancer compounds. I--Comparison between carcinostatic activity on animal tumours and inhibition of protein and nucleic acid synthesis in cell incubations.
González-Cadavid N; Cohen R; Salazar LM; Paramidani D
Acta Cient Venez; 1980; 31(2):137-47. PubMed ID: 7468081
[No Abstract] [Full Text] [Related]
7. [Metabolic behavior of tumor slices under the influence of cytostatic compounds].
Athen B; Guglielmi H
Hoppe Seylers Z Physiol Chem; 1969 Jul; 350(7):803-8. PubMed ID: 5806554
[No Abstract] [Full Text] [Related]
8. [Effects of cyclophosphamide and 2,3,5-tris-ethyleniminobenzoquinone-(1,4) on tumor cells in diffusion chambers].
Teichmann B
Arzneimittelforschung; 1965 May; 15(5):532-4. PubMed ID: 5898339
[No Abstract] [Full Text] [Related]
9. Studies on the mechanism of action of 5-aziridinyl-2,4-dinitrobenzamide (CB 1954), a selective inhibitor of the Walker tumour.
Connors TA; Melzack DH
Int J Cancer; 1971 Jan; 7(1):86-92. PubMed ID: 5546147
[No Abstract] [Full Text] [Related]
10. Walker carcinosarcoma 256 in study of anticancer agents. II. Results.
Everett J
Cancer Res; 1966 Aug; 26(8 Pt 2):942-9. PubMed ID: 4224206
[No Abstract] [Full Text] [Related]
11. In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals.
Gold J
Cancer Treat Rep; 1986 Dec; 70(12):1433-5. PubMed ID: 3791255
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies of the mechanism of tumor-induced bone marrow cytolysis.
DiStefano JF; Lysik R; Zucker S
Cancer Res; 1979 Apr; 39(4):1193-8. PubMed ID: 421203
[No Abstract] [Full Text] [Related]
14. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
[No Abstract] [Full Text] [Related]
15. Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells.
Mandel HG; Connors TA; Melzack DH; Merai K
Cancer Res; 1974 Feb; 34(2):275-80. PubMed ID: 4855748
[No Abstract] [Full Text] [Related]
16. [Metabolic study of sarcoma 45 and Walker carcinosarcoma cells during growth and anticoagulant exposure. An autoradiographic study].
Kolomina SM; Pogodina LS; Chentsov IuS; Kudriashov BA; Vasil'eva TN
Tsitol Genet; 1982; 16(5):68-73. PubMed ID: 7147343
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of bleomycin by an antifungal polyene, pentamycin, in transformed animal cells.
Nakashima T; Kuwano M; Matsui K; Komiyama S; Hiroto I
Cancer Res; 1974 Dec; 34(12):3258-61. PubMed ID: 4138969
[No Abstract] [Full Text] [Related]
18. [Studies in vivo and in vitro on the influence of 5-fluorouracil and n'-(2'-furanidyl)-5-fluorouracil on the walker carcinosarcoma 256 in the rat (author's transl)].
Mattern J; Volm M; Wayss K; Weber N
Arzneimittelforschung; 1980; 30(6):981-4. PubMed ID: 6774738
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
Norpoth K; Witting U; Rauen HM
Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
[No Abstract] [Full Text] [Related]
20. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
Gold J
Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
